DF/HCC New Member

Please welcome Dr. Kaufman who recently joined DF/HCC and is a member of the Melanoma Program

Transcript:
Hi I’m Howard Kaufman and I work at the Massachusetts General Hospital, and I recently joined the DF/HCC Melanoma Program.

My interest has been in taking care of melanoma patients and developing oncolytic viruses for the treatment of melanoma. These are viruses that get into a replicated kill-melanoma cells and then also induce an immune response.

So, lately we’ve found that combining these with other agents, both immunotherapy as well as targeted therapy, can really augment the therapeutic benefit of these viruses. And so, we are actively looking for and starting to develop collaborations with other investigators with similar interests.